On October 17, a meeting was held between the Center's management, namely Director Mykhailo Babenko, his deputy Mykhailo Lobas, and Oresta Piniazhko, Director of the Department of Health Technology Assessment and Rational Pharmacotherapy, and representatives of the project of the U.S. Agency for International Development (USAID) “Safe, Affordable, and Effective Medicines for Ukrainians” (SAFEMed) – project director Rebecca Kouler and her deputy Serhii Strashuk, technical advisor on pharmaceutical management Nataliia Valuieva, and interpreter Yuliia Shyhorina.
During the meeting, the parties discussed short-term current tasks within the cooperation and plans for the near term:
- prospects for the development of health technology assessment (HTA) in Ukraine and the establishment of an independent agency;
- establishment of a single regulatory state control authority (SCA) within the framework of European integration and in accordance with the Law on Medicinal Products;
- improving the use of medicinal product pricing tools;
- creation of a unified positive list of medicinal products;
- implementation of IT tools,
- scientific research on the prospects of using the hospital HTA tool;
- case study of a horizon scanning tool for prioritizing assessments.
We remind you that the Center's cooperation with the project has been ongoing since 2018. Within the framework of the Memorandum of Cooperation (2022) between the Center and the international organization “Management Sciences for Health” (@Management Science for Health – MSH), the implementer of the USAID-funded SAFEMed project, the project provides support for the further development of HTA in Ukraine, medicinal product pricing, and scientific and methodological support for hospital HTA.
